Lithium Ion

Lithium Ion

SCHEMBL8063209

C/C(=C\c1ccc(C(F)(F)F)cc1)C(=O)Nc1cc(Cl)ccc1C(=O)[O-].[Li+]

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 3/20 0.47
PPARG P37231 1/20 0.41
PPARD Q03181 1/20 0.41
PPARA Q07869 1/20 0.41
NR1H4 Q96RI1 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TMPRSS4 Q9NRS4 4/20 0.40
P2RX1 P51575 2/20 0.40
P2RX4 Q99571 2/20 0.40
P2RX7 Q99572 2/20 0.40
DHODH Q02127 2/20 0.39
TRPM8 Q7Z2W7 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CHRNA7 P36544 1/20 0.38
KCNK2 O95069 1/20 0.37
KCNK10 P57789 1/20 0.37
TRPV1 Q8NER1 1/20 0.37
CYP11B1 P15538 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL8065172 0.91 TMPRSS4 (0.42) GRIK1PPARGPPARDNR1H4MEN1
SCHEMBL8058427 0.89 GRIK1 (0.61) GRIK1PPARGPPARDPPARANR1H4
SCHEMBL8058422 0.89 GRIK1 (0.61) GRIK1PPARGPPARDPPARANR1H4
SCHEMBL8063210 0.88 GRIK1 (0.60) GRIK1PPARGPPARDPPARANR1H4
SCHEMBL8063207 0.88 GRIK1 (0.60) GRIK1PPARGPPARDPPARANR1H4
Lithium Ion SCHEMBL8048870 0.84 TRPM8 (0.57) MEN1KMT2ADHODHTRPM8RAB9A
SCHEMBL8064143 0.82 KDM4E (0.53) GRIK1PPARGPPARDNR1H4MEN1
SCHEMBL8064144 0.82 KDM4E (0.53) GRIK1PPARGPPARDNR1H4MEN1
SCHEMBL8060374 0.82 TRPM8 (0.57) MEN1KMT2ADHODHTRPM8RAB9A
SCHEMBL8065176 0.81 KDM4E (0.52) GRIK1PPARGPPARDNR1H4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US claimed
EP-1003712-A1 ANTHRANILIC ACID ANALOGS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-05-31 EP claimed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US claimed
WO-1999007669-A1 ANTHRANILIC ACID ANALOGS AMERICAN HOME PRODUCTS CORPORATION (US) 1999-02-18 WO claimed
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
EP-1003712-A1 ANTHRANILIC ACID ANALOGS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-05-31 EP disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed
WO-1999007669-A1 ANTHRANILIC ACID ANALOGS AMERICAN HOME PRODUCTS CORPORATION (US) 1999-02-18 WO disclosed